Johnson & Johnson

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JNJ and other ETFs, options, and stocks.

About JNJ

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
152,700
Employees152,700
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
152,700
Employees152,700

JNJ Key Statistics

Market cap
389.30B
Market cap389.30B
Price-Earnings ratio
33.00
Price-Earnings ratio33.00
Dividend yield
2.81%
Dividend yield2.81%
Average volume
6.76M
Average volume6.76M
High today
$163.49
High today$163.49
Low today
$161.59
Low today$161.59
Open price
$162.61
Open price$162.61
Volume
4.52M
Volume4.52M
52 Week high
$181.04
52 Week high$181.04
52 Week low
$150.11
52 Week low$150.11

JNJ News

Benzinga 12h
Zika Virus Market to Witness Growth by 2032, Estimates DelveInsight | Johnson and Johnson, Aurobindo Phar - Benzinga

"Zika Virus Market" (Albany, USA) DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understandi...

Zika Virus Market to Witness Growth by 2032, Estimates DelveInsight | Johnson and Johnson, Aurobindo Phar - Benzinga
Benzinga 22h
Cutaneous Mastocytosis Treatment Market | Bausch Health Companies Inc., Bayer AG, Johnson & Johnson, Mall - Benzinga

The global cutaneous mastocytosis treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of...

Cutaneous Mastocytosis Treatment Market | Bausch Health Companies Inc., Bayer AG, Johnson & Johnson, Mall - Benzinga
Yahoo Finance 3d
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results - Yahoo Finance

NEW BRUNSWICK, N.J., September 18, 2023--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on...

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results - Yahoo Finance

Analyst ratings

63%

of 24 ratings
Buy
33.3%
Hold
62.5%
Sell
4.2%

JNJ Earnings

$0.00
$0.93
$1.87
$2.80
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Q1 FY23
Q2 FY23
Q3 FY23
Estimated
$2.51 per share
Estimated$2.51 per share
Actual
Available Oct 17, Pre-Market
ActualAvailable Oct 17, Pre-Market

More JNJ News

Fortune 7d
This J&J exec sold Tylenol and Listerine. Now she runs its $27 billion medtech business

Good morning, Broadsheet readers! Former Alibaba Group adviser Wei Zhang will join the Starbucks board, Iranian women are still fighting for their rights, and a...

This J&J exec sold Tylenol and Listerine. Now she runs its $27 billion medtech business
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.